Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Coca-Cola lifts forecasts as earnings sparkle on higher prices, steady demand

by Jessica Weisman-Pitts
0 comment

Coca-Cola lifts forecasts as earnings sparkle on higher prices, steady demand

By Ananya Mariam Rajesh

(Reuters) – Coca-Cola Co on Tuesday raised its annual sales and profit forecasts for a second time this year, riding on resilient demand from consumers for its sodas, juices and energy drinks as well as higher prices.

Shares climbed 3% in early trading after the company also topped expectations for third-quarter results.

Rival PepsiCo also beat expectations and said it would hike prices next year as consumers continued to spend on products dubbed “affordable luxuries” at a time of elevated food prices and higher cost of living.

Coca-Cola’s average selling prices rose 9% in the third quarter, the company said, while overall unit case volumes increased 2%.

In an earnings call, CEO James Quincey said the company was monitoring the impact of weight-loss drugs and “there is still a lot of views out there as to what impact, if any, it will have.”

Investors have tracked comments from packaged food makers this earnings season on the potential impact from the surging popularity of weight-loss drugs such as Wegovy and Ozempic.

“It certainly feels that it has been a bit of an overreaction…as a pure liquids company and as more of a global company (Coca-Cola) will probably see the impact later than anyone,” said Markus Hansen, a portfolio manager at Vontobel Quality Growth. Coca-Cola accounts for 3.98% of Vontobel’s Global Equity strategy as of June 30.

The maker of Sprite and Fanta now sees full-year organic revenue growth of 10% to 11%, compared with its prior forecast of an increase of 8% to 9%.

Coca-Cola forecast annual core earnings per share to rise between 7% and 8%, compared to a 5% to 6% increase earlier.

Third-quarter net revenue of $11.91 billion topped estimates of $11.44 billion, while adjusted earnings of 74 cents per share also beat expectations of 69 cents, according to LSEG data.


(Reporting by Ananya Mariam Rajesh in Bengaluru; Editing by Sriraj Kalluvila)